StockWatch
·

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. Q2 FY27 Results

SPARCQ2 FY27 Results
Filing
Result:Weak· Market: Flat#Base effect
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue30.0324.8%282.1%
Total Income53.6515.6%581.7%
Expenditure77.967.5%6.8%
PBT-24.3117.6%67.9%
Net Profit-24.3917.4%67.8%
OPM—
NPM-45.46%12.78pp
EPS-0.75217.2%132.1%
View full financials

Pharma R&D cost center narrowed its net loss to ₹24.4 Cr on sharply higher revenue (up 282% YoY off a tiny base), but it remains loss-making with no turnaround to profit, capping the rating per the loss/non-turnaround rule.

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue30.0324.8%282.1%
Total Income53.6515.6%581.7%
Expenditure77.967.5%6.8%
PBT-24.3117.6%67.9%
Net Profit-24.3917.4%67.8%
OPM—
NPM-45.46%12.78pp
EPS-0.75217.2%132.1%
View full financials

Detailed report is being prepared.

Informational and educational content only. Not investment advice.